HRT Financial’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

HRT Financial’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,494	Closed	-$1K	–	3604
2022 Q4	$1K	Buy	+24,494	New	+$3.11K	﹤0.01%	2401
2022 Q2	–	Sell	-22,539	Closed	-$7K	–	4025
2022 Q1	$7K	Buy	+22,539	New	+$24.1K	﹤0.01%	2938

Other funds holding STAB

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Tucker Asset Management Littleton, Colorado $406M AUM 20.49% 1-Year Est. Return

HRT Financial's STAB Position: Q1 2023 in Review

HRT Financial sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 24,494 shares — an estimated $1K sold.

HRT Financial first reported a position in STAB in Q1 2022 and held it in 2 quarters. The position peaked at $7K in Q1 2022. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

HRT Financial reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
HRT Financial sold 24,494 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $1K.
HRT Financial first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
HRT Financial's Statera Biopharma, Inc. Common Stock position peaked at $7K in Q1 2022.
4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.